Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global veterinary active pharmaceutical ingredients market 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Synthesis type trends
2.1.5 Route of administration trends
2.1.6 Service type trends
2.1.7 Animal type trends
Chapter 3 Veterinary Active Pharmaceutical Ingredients Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for pet insurance
3.2.1.2 Surging awareness of animal health, physical, and mental well-being
3.2.1.3 Increasing demand for animal products
3.2.1.4 Favorable government initiatives
3.2.1.5 Growing pet adoption
3.2.2 Industry pitfalls & challenges
3.2.2.1 Low out of pocket expenditure on veterinary care
3.2.2.2 High cost of veterinary medicines
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By synthesis type
3.3.3 By route of administration
3.3.4 By service type
3.3.5 By animal type
3.4 COVID- 19 impact analysis
3.5 Technology landscape
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia Pacific
3.7 Supply chain analysis
3.8 Key market trends
3.9 Pipeline analysis
3.10 Porter's analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company positioning matrix
4.4 Competitive analysis of major market players
4.5 Strategy dashboard, 2022
Chapter 5 Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Type (USD Million)
5.1 Key trends, by type
5.2 Anti-infectives
5.3 Anti-parasitics
5.4 Vaccines
5.5 Hormones
5.6 Biologics
5.7 Anti-inflammatory
5.8 Other APIs
Chapter 6 Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Synthesis Type (USD Million)
6.1 Key trends, by synthesis type
6.2 Chemical based API
6.3 Biological API
6.4 Highly potent API (HPAPI)
Chapter 7 Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Route of Administration (USD Million)
7.1 Key trends, by route of administration
7.2 Oral
7.3 Injectable
7.4 Topical
7.5 Other routes
Chapter 8 Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Service Type (USD Million)
8.1 Key trends, by service type
8.2 In-house
8.3 Contract outsourcing
8.3.1 Contract development
8.3.2 Contract manufacturing
Chapter 9 Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Animal Type (USD Million)
9.1 Key trends, by animal type
9.2 Companion animals
9.3 Livestock animals
Chapter 10 Veterinary Active Pharmaceutical Ingredients Market Size and Forecast, By Region (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Alivira Animal Health Ltd.
11.2 SUANFARMA
11.3 Procyon Life Sciences
11.4 Jiangsu Lingyun Pharmaceutical Co., Ltd.
11.5 Ofichem Group
11.6 NGL Fine-Chem Ltd
11.7 Huvepharma
11.8 Excel Veterinary Healthcare
11.9 Menadiona
11.10 Indukern Group
11.11 Vetpharma (Insud Pharma)
11.12 Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
